Assessing for comorbidities, determinants and disability during TB treatment

Assessing for comorbidities, determinants and disability during TB treatment

Saved in:

Bibliographic Details
Main Authors:	K. Viney, A. Baddeley, E. Jaramillo, M. Calvi, A. Carlqvist, F. Mavhunga
Format:	Article
Language:	English
Published:	International Union Against Tuberculosis and Lung Disease (The Union) 2024-02-01
Series:	IJTLD Open
Online Access:	https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000002/art00008
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comprehensive care for people affected by TB: addressing TB-associated disabilities
by: M. Calvi, et al.
Published: (2024-05-01)

Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
by: The Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):, et al.
Published: (2024-05-01)

Global reporting on TB in children and adolescents: how far have we come and what remains to be done?
by: S. Verkuijl, et al.
Published: (2024-01-01)

Prevalence of TB-related symptoms and self-reported disability among adult TB survivors
by: A.K. McDonald, et al.
Published: (2024-12-01)

Determinant of catastrophic costs associated with treatment for rifampicin-resistant TB in households in the Republic of Moldova
by: A. Ciobanu, et al.
Published: (2024-06-01)

Modeling TB-HIV Syndemic and Treatment
by: Cristiana J. Silva, et al.
Published: (2014-01-01)

Accelerating TB regimen development: introducing FAST-TB
by: T. Devezin, et al.
Published: (2024-11-01)

Severe outcomes among adults with TB during COVID-19
by: T. Jacobs, et al.
Published: (2024-07-01)

Person-centred language for describing stratified approaches to TB treatment
by: M. Nash, et al.
Published: (2025-01-01)

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB
by: R. Crowder, et al.
Published: (2024-10-01)

Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment
by: Damani A. Piggott, et al.
Published: (2011-01-01)

Post-TB sequelae in adolescent pulmonary TB survivors
by: C. Cesilia, et al.
Published: (2025-01-01)

TB survivors: why curing TB is sometimes not enough
by: E. Pontali, et al.
Published: (2024-12-01)

Quantifying sputum production success during community-based screening for TB
by: P.J Kitonsa, et al.
Published: (2024-11-01)

Assessment of Haematological Parameters in Drug-Resistant TB
by: Abdulrazzaq Neamah Zghair
Published: (2023-03-01)

Yield of TB screening in prisons in Tajikistan
by: S. Moe, et al.
Published: (2024-08-01)

TB and poverty: the effect of rifampicin-resistant TB on household income
by: A. Ciobanu, et al.
Published: (2024-04-01)

Timing of recurrence after treatment of pulmonary TB
by: C.T. Mithunage, et al.
Published: (2024-10-01)

Differentiated TB care matrix: Validating an assessment tool for healthcare workers providing differentiated TB care using Delphi technique
by: Riswana S. Ansari, et al.
Published: (2025-03-01)

Applying ‘timeliness’ to the screening and prevention of TB in household contacts of pulmonary TB patients
by: A. D. Harries, et al.
Published: (2024-02-01)

A call to invest in post-TB lung disease to halt TB transmission in communities
by: P. M. Mbelele, et al.
Published: (2024-02-01)

Priapism: Comorbid Factors and Treatment Outcomes in a Contemporary Series
by: Henry P. Gottsch, et al.
Published: (2012-01-01)

Timeliness metrics for screening and preventing TB in household contacts of pulmonary TB patients in Kenya
by: D. Nair, et al.
Published: (2024-01-01)

Monocytes as Regulators of Inflammation and HIV-Related Comorbidities during cART
by: Joshua J. Anzinger, et al.
Published: (2014-01-01)

TB preventive therapy: uptake and time to initiation during implementation of ‘7-1-7’
by: A.D. Harries, et al.
Published: (2024-04-01)

The Emergence of Extensively Drug-Resistant Tuberculosis (TB): TB/HIV Coinfection, Multidrug-Resistant TB and the Resulting Public Health Threat from Extensively Drug-Resistant TB, Globally and in Canada
by: Paul E Alexander, et al.
Published: (2007-01-01)

Impact of Undetected Comorbidity on Treatment and Outcomes of Breast Cancer
by: Robert I. Griffiths, et al.
Published: (2014-01-01)

Impact of bedaquiline resistance probability on treatment decision for rifampicin-resistant TB
by: T.P.H. Trang, et al.
Published: (2024-09-01)

Treatment outcomes in NTM-PD in a high TB burden context
by: S. Kang, et al.
Published: (2024-12-01)

Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
by: S. Sweeney, et al.
Published: (2024-07-01)

A Systematic Review of the Epidemiology, Immunopathogenesis, Diagnosis, and Treatment of Pleural TB in HIV- Infected Patients
by: A. Aljohaney, et al.
Published: (2012-01-01)

Impact of media coverage on the transmission dynamics of TB with vaccines and treatment.
by: Kumneger Tadesse Mulugeta, et al.
Published: (2025-01-01)

A TB Model with Infectivity in Latent Period and Imperfect Treatment
by: Juan Wang, et al.
Published: (2012-01-01)

2022 TB programme review in Pakistan: strengthening governance, with better patient diagnosis and treatment
by: M. van den Boom, et al.
Published: (2024-03-01)

Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes
by: J. Limo, et al.
Published: (2025-01-01)

Risk of TB disease in individuals with cancer
by: T. Diefenbach-Elstob, et al.
Published: (2025-01-01)

Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines
by: D. Evans, et al.
Published: (2024-06-01)

Applicability of TB-LAMP test for diagnosis of pulmonary TB among HIV-positive individuals
by: B. Muriithi, et al.
Published: (2025-01-01)

Dhat Syndrome: Epidemiology, Risk Factors, Comorbidities, Diagnosis, Treatment, and Management
by: Yukino N. Strong, et al.
Published: (2022-10-01)

Assessing Pain in Children with Intellectual Disabilities
by: Lynn M Breau, et al.
Published: (2009-01-01)